Publication | Open Access
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
21
Citations
18
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1